keyword
https://read.qxmd.com/read/38632977/efficacy-of-risankizumab-across-subgroups-in-patients-with-active-psoriatic-arthritis-a-post-hoc-integrated-analysis-of-the-phase-3-keepsake-1-and-keepsake-2-randomized-controlled-trials
#21
JOURNAL ARTICLE
Joseph F Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla, Cuiyong Yue, Huzefa Photowala, Blair Kaplan, Lars Erik Kristensen
In the KEEPsAKE 1 (NCT03675308) and KEEPsAKE 2 (NCT03671148) phase 3 trials, risankizumab demonstrated greater efficacy compared with placebo in patients with active psoriatic arthritis (PsA). This post hoc integrated analysis evaluated achieving the following efficacy outcomes at weeks 24 and 52 by baseline demographics and clinical characteristics: ≥20%/50%/70% improvement in American College of Rheumatology response criteria (ACR20/50/70), ≥90% improvement in Psoriasis Area and Severity Index, minimal disease activity status, Low Disease Activity status (Disease Activity in Psoriatic Arthritis), and minimal clinically important difference in pain...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38632943/external-validation-of-the-risk-assessment-model-of-venous-thromboembolism-in-multicenter-internal-medicine-inpatients
#22
MULTICENTER STUDY
Xiaolan Chen, Hongning Shi, Jiaqi Chang, Wenjia Guo, Yuanhua Yang, Yong Wang, Lei Pan
To external validate the risk assessment model (RAM) of venous thromboembolism (VTE) in multicenter internal medicine inpatients. We prospectively collected 595 internal medical patients (310 with VTE patients, 285 non-VTE patients) were from Beijing Shijitan Hospital, Beijing Chaoyang Hospital, and the respiratory department of Beijing Tsinghua Changgeng Hospital from January 2022 to December 2022 for multicenter external validation. The prediction ability of Caprini RAM, Padua RAM, The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) RAM, and Shijitan (SJT) RAM were compared...
2024: Clinical and Applied Thrombosis/hemostasis
https://read.qxmd.com/read/38632528/immune-checkpoint-inhibitors-in-cancer-patients-with-rheumatologic-preexisting-autoimmune-diseases-a-systematic-review-and-meta-analysis
#23
Xin Liu, Su Li, Liyuan Ke, Hongxia Cui
BACKGROUND: Patients with rheumatologic preexisting autoimmune disease (PAD) have not been enrolled in clinical trials of immune checkpoint inhibitors (ICIs). Therefore, the risks and benefits of ICI therapy in such patients are unclear. Herein, we investigated the safety and efficacy of ICIs in rheumatologic PAD patients through a meta-analysis. METHODS: The PubMed, Cochrane Library, Embase and Web of Science databases were searched for additional studies. We analyzed the following data through Stata software: incidence of total irAEs (TirAEs), rate of flares, incidence of new on-set irAEs, rate of discontinuation, objective response rate (ORR) and disease control rate (DCR)...
April 17, 2024: BMC Cancer
https://read.qxmd.com/read/38631846/use-of-risk-chart-algorithms-for-the-identification-of-psoriatic-arthritis-patients-at-high-risk-for-cardiovascular-disease-findings-derived-from-the-project-carma-cohort-after-a-7-5-year-follow-up-period
#24
JOURNAL ARTICLE
Jessica Polo Y La Borda, Santos Castañeda, Elena Heras-Recuero, Fernando Sánchez-Alonso, Zulema Plaza, Carmen García Gómez, Ivan Ferraz-Amaro, Jesús Tomás Sanchez-Costa, Olga Carmen Sánchez-González, Ana Isabel Turrión-Nieves, Ana Perez-Alcalá, Carolina Pérez-García, Carlos González-Juanatey, Javier Llorca, Miguel Angel Gonzalez-Gay
OBJECTIVE: To assess the predictive value of four cardiovascular (CV) risk algorithms for identifying high-risk psoriatic arthritis (PsA) patients. METHODS: Evaluation of patients with PsA enrolled in the Spanish prospective project CARdiovascular in RheuMAtology. Baseline data of 669 PsA patients with no history of CV events at the baseline visit, who were followed in rheumatology outpatient clinics at tertiary centres for 7.5 years, were retrospectively analysed to test the performance of the Systematic Coronary Risk Assessment (SCORE), the modified version (mSCORE) European Alliance of Rheumatology Associations (EULAR) 2015/2016, the SCORE2 algorithm (the updated and improved version of SCORE) and the QRESEARCH risk estimator version 3 (QRISK3)...
April 17, 2024: RMD Open
https://read.qxmd.com/read/38631525/limb-arteries-involvement-assessed-by-fdg-pet-ct-at-diagnosis-of-giant-cell-arteritis-and-risk-of-relapse-an-observational-study
#25
JOURNAL ARTICLE
Geoffroy Peyrac, Arthur Mageau, Augustin Gaudemer, Khadija Benali, Julien Rohmer, Jean-Francois Alexandra, Andrey Strukov, Sebastien Ottaviani, Thomas Papo, Karim Sacre
Introduction Steroids and anti-IL6 biotherapy are highly effective in obtaining remission in patients with giant cell arteritis (GCA) but the risk of relapses remains high. We aimed to identify predictors of relapse in GCA. Methods All consecutive patients admitted with a new diagnosis of GCA - according to the 2022 American College of Rheumatology/EULAR (ACR/EULAR) classification criteria - between May 2011 and May 2022 were eligible for this study. The primary outcome was the GCA relapse rate over the 36-months follow up...
April 15, 2024: Joint, Bone, Spine: Revue du Rhumatisme
https://read.qxmd.com/read/38631369/diagnostic-approach-to-interstitial-lung-diseases-associated-with-connective-tissue-diseases
#26
JOURNAL ARTICLE
Ana C Zamora, Lewis J Wesselius, Michael B Gotway, Henry D Tazelaar, Alejandro Diaz-Arumir, Vivek Nagaraja
Interstitial lung disorders are a group of respiratory diseases characterized by interstitial compartment infiltration, varying degrees of infiltration, and fibrosis, with or without small airway involvement. Although some are idiopathic (e.g., idiopathic pulmonary fibrosis, idiopathic interstitial pneumonias, and sarcoidosis), the great majority have an underlying etiology, such as systemic autoimmune rheumatic disease (SARD, also called Connective Tissue Diseases or CTD), inhalational exposure to organic matter, medications, and rarely, genetic disorders...
April 17, 2024: Seminars in Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38631342/receipt-of-rheumatology-care-and-lupus-specific-labs-among-young-adults-with-systemic-lupus-erythematosus-a-us-medicare-retention-in-care-cohort-study
#27
JOURNAL ARTICLE
Maria Schletzbaum, W Ryan Powell, Shivani Garg, Joseph Kramer, Brad C Astor, Andrea Gilmore-Bykovskyi, Amy J Kind, Christie M Bartels
OBJECTIVE: In systemic lupus erythematosus, poor disease outcomes occur in young adults, patients identifying as Black or Hispanic, and socioeconomically disadvantaged patients. These identities and social factors differentially shape care access and quality that contribute to lupus health disparities in the US. Thus, our objective was to measure markers of care access and quality, including rheumatology visits (longitudinal care retention) and lupus-specific serology testing, by race and ethnicity, neighborhood disadvantage, and geographic context...
April 17, 2024: Lupus
https://read.qxmd.com/read/38630413/inborn-errors-of-immunity-in-jordan-first-report-from-a-tertiary-referral-center
#28
JOURNAL ARTICLE
Raed Alzyoud, Motasem Alsuweiti, Heba Maaitah, Boshra Aladaileh, Mohammed Noubani, Hamazh Nsour
PURPOSE: Inborn errors of immunity (IEI) are a heterogeneous group of diseases with variable clinical phenotypes. This study was conducted to describe the epidemiology, clinical presentations, treatment, and outcome of IEI in Jordanian children. METHODS: A retrospective data analysis was conducted for children under 15 years diagnosed with IEI from the pediatric Allergy, Immunology, and Rheumatology Division-based registry at Queen Rania Children's Hospital, Amman, Jordan, between 2010 and 2022...
April 17, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38629371/translation-research-in-therapeutic-approaches-from-conventional-to-novel-nano-therapeutics-for-rheumatoid-arthritis-treatment
#29
JOURNAL ARTICLE
Laxmi Rani, Pooja Mathur, Ravinder Verma, Vivek Kumar, Ashwini Kumar Mishra, Pravat Kumar Sahoo
Rheumatoid arthritis is a systemic autoimmune disorder related to joint inflammation, bone erosion, and deformity. Numerous studies indicate that the causes and consequences of RA are still being debated, and therapeutic strategies are in the translation stage. Non-steroidal anti-inflammatory drugs continue to be often used to relieve pain. Still, due to their poor efficacy, failure to halt the spread of the disease, and undesirable adverse effects, they are no longer regarded as first-line treatments. The development of biologic DMRDs designed to reduce the inflammatory response led to substantial changes to the strategy for managing this disease...
April 15, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38629107/a-content-analysis-of-medication-adherence-material-in-patient-educational-resources-about-gout
#30
JOURNAL ARTICLE
Yasaman Emad, Christina Derksen, Keith J Petrie, Nicola Dalbeth
OBJECTIVE: This study aimed to investigate how medication adherence is addressed in online gout resources in six countries. We investigated how often adherence was referred to, the strategies suggested to improve patient adherence, and the types of nonadherence that were targeted. We also examined the readability of the adherence material. METHODS: A content analysis was conducted on 151 online gout resources from medical and health organisations in six predominantly English-speaking countries...
2024: Rheumatology Advances in Practice
https://read.qxmd.com/read/38629069/higher-odds-of-periodontitis-in-systemic-lupus-erythematosus-compared-to-controls-and-rheumatoid-arthritis-a-systematic-review-meta-analysis-and-network-meta-analysis
#31
Ping Ren Tan, Aaron J L Lee, Joseph J Zhao, Yiong Huak Chan, Jia Hui Fu, Margaret Ma, Sen Hee Tay
INTRODUCTION: Periodontitis as a comorbidity in systemic lupus erythematosus (SLE) is still not well recognized in the dental and rheumatology communities. A meta-analysis and network meta-analysis were thus performed to compare the (i) prevalence of periodontitis in SLE patients compared to those with rheumatoid arthritis (RA) and (ii) odds of developing periodontitis in controls, RA, and SLE. METHODS: Pooled prevalence of and odds ratio (OR) for periodontitis were compared using meta-analysis and network meta-analysis (NMA)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628329/sarcoidosis-presenting-as-multiple-osseous-lesions
#32
Maryam Riaz, Swastika Jha
Sarcoidosis is a multisystem inflammatory condition presenting with the formation of noncaseating granulomas. These granulomas can be found in nearly every organ of the body, but in 90% of cases the lungs are involved. Osseous manifestations are seen in only 3% to 13% of cases and are typically seen alongside the more common pulmonary manifestations. These lesions can be misdiagnosed as metastatic cancer so biopsy, along with clinical correlation and exclusion of other diseases, is necessary to make the diagnosis...
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38627861/unveiling-the-clinical-spectrum-of-relapsing-polychondritis-insights-into-its-pathogenesis-novel-monogenic-causes-and-therapeutic-strategies
#33
REVIEW
Blanca E R G Bica, Alexandre Wagner S de Souza, Ivânio Alves Pereira
Relapsing polychondritis is a rare multisystem disease involving cartilaginous and proteoglycan-rich structures. The diagnosis of this disease is mainly suggested by the presence of flares of inflammation of the cartilage, particularly in the ears, nose or respiratory tract, and more rarely, in the presence of other manifestations. The spectrum of clinical presentations may vary from intermittent episodes of painful and often disfiguring auricular and nasal chondritis to an occasional organ or even life-threatening manifestations such as lower airway collapse...
April 16, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38627860/hemophagocytic-lymphohistiocytosis-and-macrophage-activation-syndrome-two-rare-sides-of-the-same-devastating-coin
#34
REVIEW
Flavio Sztajnbok, Adriana Rodrigues Fonseca, Leonardo Rodrigues Campos, Kátia Lino, Marta Cristine Félix Rodrigues, Rodrigo Moulin Silva, Rozana Gasparello de Almeida, Sandro Félix Perazzio, Margarida de Fátima Fernandes Carvalho
Hemophagocytic lymphohistiocytosis (HLH) is a rare genetic hyperinflammatory syndrome that occurs early in life. Macrophage activation syndrome (MAS) usually refers to a secondary form of HLH associated with autoimmunity, although there are other causes of secondary HLH, such as infections and malignancy. In this article, we reviewed the concepts, epidemiology, clinical and laboratory features, diagnosis, differential diagnosis, prognosis, and treatment of HLH and MAS. We also reviewed the presence of MAS in the most common autoimmune diseases that affect children...
April 16, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38627838/seronegative-primary-sj%C3%A3-gren-s-syndrome-a-distinct-subtype-of-primary-sj%C3%A3-gren-s-syndrome-in-chinese-patients
#35
JOURNAL ARTICLE
Jingying Lan, Chaoqiong Deng, Heqing Huang, Peishi Rao, Yangchun Chen, Yingying Shi, Jie Chen, Guixiu Shi, Yuan Liu, Shiju Chen
BACKGROUND: To investigate the clinical and immune characteristics of patients with primary Sjögren's syndrome (pSS) who were negative for anti-Sjögren's-syndrome-related antigen A antibodies (anti-SSA) and anti-Sjögren's-syndrome-related antigen B antibodies (anti-SSB) in Chinese population. METHODS: A retrospective study were performed and 232 patients with pSS were analyzed. Patients positive for anti-SSA or/and anti-SSB were termed as seropositive pSS, and these negative for both anti-SSA and anti-SSB (non-antinuclear antibodies) as seronegative pSS...
April 16, 2024: BMC rheumatology
https://read.qxmd.com/read/38627367/bilateral-tibial-fractures-associated-with-powered-exoskeleton-use-in-complete-spinal-cord-injury-a-case-report-literature-review
#36
JOURNAL ARTICLE
John Mahon, Lily Nolan, David O'Sullivan, Mark Curtin, Aiden Devitt, Colin G Murphy
INTRODUCTION: Powered robotic exoskeleton (PRE) physiotherapy programmes are a relatively novel frontier which allow patients with reduced mobility to engage in supported walking. Research is ongoing regarding their utility, risks, and benefits. This article describes the case of two fractures occurring in one patient using a PRE. CASE: We report the case of a 54 year old man who sustained bilateral tibial fractures while using a PRE, on a background of T10 AIS A SCI...
April 16, 2024: Spinal Cord Series and Cases
https://read.qxmd.com/read/38627327/cluster-analysis-of-long-covid-symptoms-for-deciphering-a-syndrome-and-its-long-term-consequence
#37
JOURNAL ARTICLE
J Niewolik, M Mikuteit, S Klawitter, D Schröder, A Stölting, K Vahldiek, S Heinemann, F Müller, Gmn Behrens, F Klawonn, A Dopfer-Jablonka, S Steffens
The long-term symptoms of COVID-19 are the subject of public and scientific discussions. Understanding how those long COVID symptoms co-occur in clusters of syndromes may indicate the pathogenic mechanisms of long COVID. Our study objective was to cluster the different long COVID symptoms. We included persons who had a COVID-19 and assessed long-term symptoms (at least 4 weeks after first symptoms). Hierarchical clustering was applied to the symptoms as well as to the participants based on the Euclidean distance h of the log-values of the answers on symptom severity...
April 16, 2024: Immunologic Research
https://read.qxmd.com/read/38627280/management-of-granulomatosis-with-polyangiitis-complicated-by-intestinal-perforation-and-pancytopenia-a-case-report-and-literature-review
#38
REVIEW
Svitlana Smiyan, Olena Dyadyk, Oksana Kvasnitska, Olexandra Makhovska, Zhanna Antiuk, Taras Bidovanets, Roman Komorovsky
Granulomatosis with polyangiitis is a systemic vasculitis. While the classic triad typically comprises otorhinolaryngologic, pulmonary, and renal manifestations, it is essential to recognize that granulomatosis with polyangiitis can affect any organ. Furthermore, reports have documented less common sites of involvement, such as the gastrointestinal tract. In this case-based review, we focus on a case of granulomatosis with polyangiitis presenting with intestinal perforation and the added challenge of concurrent pancytopenia...
April 17, 2024: Rheumatology International
https://read.qxmd.com/read/38627240/prosthetic-infections-following-tocilizumab-treatment-in-patients-with-rheumatoid-arthritis
#39
JOURNAL ARTICLE
A Louters, M Van Oosterhout, L Burgemeister, N T Jessurun, J A Van Lint
No abstract text is available yet for this article.
April 16, 2024: Rheumatology
https://read.qxmd.com/read/38627226/diagnosis-treatment-and-follow-up-of-giant-cell-arteritis-a-retrospective-multicenter-study
#40
JOURNAL ARTICLE
Mi-Kyoung Kang, Yooha Hong, Yoo Hwan Kim, Hong-Kyun Park, Soo-Kyoung Kim, Jong-Hee Sohn, Jiyoung Kim, Ki-Han Kwon, Soo-Jin Cho
BACKGROUND AND PURPOSE: Giant-cell arteritis (GCA) is the most common type of vasculitis in the elderly and is associated with high risks of visual loss and recurrence. Owing to its rarity in Asian populations, the current clinical interventions for these patients are not well known. Here we aimed to characterize the current management status of patients with GCA using Korean multicenter data. METHODS: This retrospective study analyzed medical records of patients with GCA at six Korean university hospitals from February 2009 to November 2022...
April 2, 2024: Journal of Clinical Neurology
keyword
keyword
163451
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.